Matthew Sappern: There are a lot of people who feel that artificial intelligence and machine learning is much further along than it really is. There is so much data out there right now. I think that’s an important first step. There’s data and there’s actionable data or what some of my colleagues call the ground
Sramana Mitra: We’re seeing an increasing amount of AI applications in the healthcare IT domain. I don’t know if you’re familiar with this announcement that we recently made of a European partnership with the European Institute of Innovation and Technology and their digital health arm. 115 companies from Europe are going to be accelerated within the
Sramana Mitra: In the healthcare space, where are some of the other areas where you see the possibilities of this kind of pattern recognition and interventions based on pattern recognition? Matthew Sappern: There are so many. Take the ICU for instance. You walk into an ICU. A typical patient has multiple telemetry devices hooked up.
Matthew Sappern: Where computers are so helpful with that, as you can imagine, is computers don’t get tired. They’re not getting coffee or arguing with someone. They look at the same series of data the same way every time. Once we figured out the ability to interpret these waves, we’re able to let the doctors
I have been talking about the applications of AI on Healthcare IT problems. Here is a great case study. Sramana Mitra: Let’s start by having you introduce yourself as well as PeriGen to our audience. Matthew Sappern: I’m the CEO of of PeriGen. PeriGen is a software developer. We make software as a medical device.
Sramana Mitra: The story that you described from 1995 to 2008 is not Perigen? Emily Hamilton: Correct. Perigen acquired all of the assets of that company. Sramana Mitra: Who’s Perigen? Matthew Sappern: Perigen is actually the combination of a company called E&C Medical, which was based in Tel Aviv that was trying to do pretty
Sramana Mitra: How many hospitals, for instance, were you able to sell your product to in that early phase right after getting the prototype? Emily Hamilton: Almost all of the hospitals in Montreal. We have two medical schools here. I had colleagues in many of the hospitals who were former students or colleagues for many
Sramana Mitra: When you talk about timing, what year are we talking about? Emily Hamilton: Back in mid-1990s. Sramana Mitra: So you got a bunch of grants to get this thing off the ground. Emily Hamilton: It wasn’t exactly a grant in the traditional sense. This was money which was intended to foster research, which